NPI Lens

Bryce Abram Mendelsohn, M.D.

NPI 1497071963ActiveIndividual· Medical Genetics, Clinical Genetics (M.D.)· Oakland, CA

Medical Genetics, Clinical Genetics (M.D.) (M.D.) in Oakland, California, licensed in CA, with an NPI issued in April 2010. Part D covered 82 prescriptions written in 2024, 63% of them generic. Biomarin Pharmaceutical Inc. reported $118.21 in payments in 2025, mostly food and beverage.

Overview

NPI1497071963
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 8, 2010
Last updated in NPPESDec 17, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Medical Genetics, Clinical Genetics (M.D.) Primary207SG0201XA120784CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Medical Genetics and Genomics (CA)

Part D prescriptions in 2024

Prescriptions (claims)82 · 84 30-day fills
Total drug cost$558,334
Generic share63% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$118.21 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Biomarin Pharmaceutical Inc.$118.211

What the 2025 payments were for

  • Food and Beverage$118.21 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Medical Genetics, Clinical Genetics (M.D.) providers in Oakland

All Medical Genetics, Clinical Genetics (M.D.) providers in California →